1. Home
  2. ANEB vs LGL Comparison

ANEB vs LGL Comparison

Compare ANEB & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANEB
  • LGL
  • Stock Information
  • Founded
  • ANEB 2020
  • LGL 1917
  • Country
  • ANEB United States
  • LGL United States
  • Employees
  • ANEB N/A
  • LGL N/A
  • Industry
  • ANEB Biotechnology: Pharmaceutical Preparations
  • LGL Industrial Machinery/Components
  • Sector
  • ANEB Health Care
  • LGL Technology
  • Exchange
  • ANEB Nasdaq
  • LGL Nasdaq
  • Market Cap
  • ANEB 36.7M
  • LGL 31.5M
  • IPO Year
  • ANEB 2021
  • LGL N/A
  • Fundamental
  • Price
  • ANEB $1.47
  • LGL $6.74
  • Analyst Decision
  • ANEB Buy
  • LGL
  • Analyst Count
  • ANEB 1
  • LGL 0
  • Target Price
  • ANEB $8.00
  • LGL N/A
  • AVG Volume (30 Days)
  • ANEB 13.1K
  • LGL 4.3K
  • Earning Date
  • ANEB 02-21-2025
  • LGL 03-31-2025
  • Dividend Yield
  • ANEB N/A
  • LGL N/A
  • EPS Growth
  • ANEB N/A
  • LGL 66.76
  • EPS
  • ANEB N/A
  • LGL 0.07
  • Revenue
  • ANEB N/A
  • LGL $4,130,000.00
  • Revenue This Year
  • ANEB N/A
  • LGL N/A
  • Revenue Next Year
  • ANEB N/A
  • LGL N/A
  • P/E Ratio
  • ANEB N/A
  • LGL $97.35
  • Revenue Growth
  • ANEB N/A
  • LGL 26.49
  • 52 Week Low
  • ANEB $0.80
  • LGL $4.86
  • 52 Week High
  • ANEB $3.30
  • LGL $6.99
  • Technical
  • Relative Strength Index (RSI)
  • ANEB 44.55
  • LGL 55.84
  • Support Level
  • ANEB $1.45
  • LGL $6.40
  • Resistance Level
  • ANEB $1.72
  • LGL $6.98
  • Average True Range (ATR)
  • ANEB 0.14
  • LGL 0.30
  • MACD
  • ANEB -0.01
  • LGL -0.02
  • Stochastic Oscillator
  • ANEB 22.28
  • LGL 68.92

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

Share on Social Networks: